Sham Litigation Claims Nixed In Androgel Pay-For-Delay MDL
A Georgia federal judge on Friday dismissed antitrust allegations that Solvay Pharmaceuticals Inc. filed sham patent infringement litigation against generic rivals in order to delay the entry of competing versions of...To view the full article, register now.
Already a subscriber? Click here to view full article